Acquisition context Körber Tissue has been integrated into Valmet as the Tissue Converting business unit since November 2023, signaling a shift in ownership and potential alignment with Valmet’s global sales channels and product roadmap.

Market positioning As a mid-sized player with estimated revenue between 10 and 25 million USD and 51-200 employees, the company occupies a niche in industrial tissue converting, presenting opportunities to engage through Valmet’s broader customer base and complementary product offerings.

Expansion potential With the transition to Valmet’s Tissue Converting unit, there may be opportunities to upsell integrated converting solutions, upgrades, or service contracts that align with Valmet’s portfolio and existing installed base.

Geographic focus Headquartered in Lucca, Tuscany, Italy, there is potential to target European-based tissue converters and manufacturers in nearby regions, leveraging local proximity for demonstrations, service, or on-site support.

Competitive landscape Compared to peers with smaller footprints or larger scale, Körber Tissue’s profile suggests a need for targeted maintenance, parts support, and process optimization offerings to maintain efficiency within a transitioning business unit under Valmet.